TrialBreast cancer research and treatment2015

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.

Brian Leyland-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.